Other substances

beta-CCM

Cholecystokinin (CCK) receptor inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

beta-CCM on PubChem

Synonyms

BRD-K28680267; beta-Carboline-3-carboxylic acid methyl ester

 

Structure image - beta-CCM

COC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2

Supporting references

Link Tested on Impact factor Notes Publication date
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels
in silico 4.86

In silico screening of potential ACE2 agonists. Theoretical amelioration of ACE2 depletion by virus attachment.

 Jun/27/2020
Export (.csv)